title: Assessing and Treating Patients With Neuropathic Pain.
abstract: Neuropathic pain (NP) is a significant source of suffering, disability, and impairment, as well as an enormous cost to society. Historically, pharmacologic treatment has been limited to drugs approved for other conditions, including anticonvulsants, antidepressants, antiarrhythmics, and opioids, but in the past 2 decades several drugs have been approved by the Food and Drug Administration specifically for NP. Understanding the underlying pathophysiology and clinical presentation of the various causes of NP states facilitates a rational selection of pharmacologic, interventional, rehabilitative, and psychological options for reducing pain and maximizing function.
authors.affiliation: Rehabilitation Institute of Chicago, Center for Pain Management, 980 North Michigan Ave, Suite 800, Chicago, IL 60611.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Scholten
authors.affiliation: Department of Physical Medicine and Rehabilitation, Department of Physical Therapy and Human Movement Sciences, Northwestern University, Evanston, IL.
authors.forename: R Norman
authors.initials: RN
authors.lastname: Harden
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D006801:Humans; D009437:Neuralgia / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D059408:Pain Management / Q000379:methods*; D010147:Pain Measurement; D010810:Physical and Rehabilitation Medicine / Q000379:methods*; D011788:Quality of Life
chemical_list: D000700:Analgesics